NICE guidance on erlotinib for the maintenance treatment of non-small-cell lung cancer.
作者信息
Rinaldi Fiona, George Elisabeth, Clark Peter
出版信息
Lancet Oncol. 2011 Aug;12(8):728-30. doi: 10.1016/s1470-2045(11)70177-2.
Abstract
摘要
相似文献
1
NICE guidance on erlotinib for the maintenance treatment of non-small-cell lung cancer.
Lancet Oncol. 2011 Aug;12(8):728-30. doi: 10.1016/s1470-2045(11)70177-2.
2
NICE guidance on erlotinib for first-line treatment of EGFR-TK mutation-positive advanced or metastatic non-small-cell lung cancer.英国国家卫生与临床优化研究所（NICE）关于厄洛替尼用于表皮生长因子受体酪氨酸激酶（EGFR-TK）突变阳性的晚期或转移性非小细胞肺癌一线治疗的指南。
Lancet Oncol. 2012 Aug;13(8):764-5. doi: 10.1016/s1470-2045(12)70296-6.
3
Erlotinib for the treatment of non-small-cell lung cancer.
Lancet Oncol. 2009 Jan;10(1):15-6. doi: 10.1016/s1470-2045(08)70283-3.
4
Time for molecularly targeted maintenance therapy for non-small-cell lung cancer?非小细胞肺癌分子靶向维持治疗的时机到了吗？
Lancet Oncol. 2010 Jun;11(6):500-1. doi: 10.1016/S1470-2045(10)70120-0. Epub 2010 May 20.
5
[Erlotinib in non-small cell lung cancer].[厄洛替尼用于非小细胞肺癌]
Gan To Kagaku Ryoho. 2011 Jun;38(6):896-900.
6
Erlotinib-associated alopecia in a lung cancer patient.一名肺癌患者出现的厄洛替尼相关性脱发。
J Thorac Oncol. 2007 Dec;2(12):1136-8. doi: 10.1097/JTO.0b013e31815ba7f9.
7
Erlotinib in lung cancer.厄洛替尼用于肺癌治疗。
N Engl J Med. 2005 Oct 20;353(16):1739-41; author reply 1739-41. doi: 10.1056/NEJMc052173.
8
Erlotinib in lung cancer.厄洛替尼用于肺癌治疗。
N Engl J Med. 2005 Oct 20;353(16):1739-41; author reply 1739-41.
9
Erlotinib in lung cancer.厄洛替尼用于治疗肺癌。
N Engl J Med. 2005 Oct 20;353(16):1739-41; author reply 1739-41.
10
Erlotinib or gefitinib for non-small-cell lung cancer.厄洛替尼或吉非替尼用于治疗非小细胞肺癌。
N Engl J Med. 2011 Jun 16;364(24):2367; author reply 2368. doi: 10.1056/NEJMc1103918.
Zotero 插件